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Abstract
Bacillus thuringiensis is used to produce biopesticides against target-insects of importance 
in agroindustry and human health. However, B. thuringiensis can carry the same entero-
toxin-encoding genes as Bacillus cereus, suggesting a potential risk of food poisoning. 
The objective of this work was to study the application of gamma radiation to eliminate 
spores in biopesticides based on B. thuringiensis serovar israelensis in order to avoid 
the liberation of these spores in the environment. The application of 20 kGy of radiation 
ensures total inactivation of the spores in the insecticide without changing the larvicidal 
activity. Results showed that it is possible to develop formulations containing B. thuring-
iensis serovar israelensis (IPS-82) eliminating viable spores with gamma radiation without 
affecting the larvicidal activity. Irradiated formulations would be safer for the environment 
and humans since the elimination of viable spores abolishes the pathogenic potential of 
B. thuringiensis strains.
Keywords: biopesticides, gamma radiation, larvicidal insecticides.
Resumo
Bacillus thuringiensis é usado na produção de biopesticidas contra insetos-alvo de impor-
tância na agroindústria e na saúde pública. Contudo, B. thuringiensis pode apresentar os 
mesmos genes codificadores de enterotoxinas presentes em Bacillus cereus, sugerindo 
a possível existência de risco para intoxicação alimentar. O objetivo deste trabalho foi 
estudar a aplicação de radiação gama para a eliminação de esporos em preparações 
de biopesticidas de B. thuringiensis sorovar israelensis de forma a se evitar a liberação 
de esporos viáveis no ambiente. Observou-se que a aplicação de 20 kGy garante a ina-
tivação total dos esporos no inseticida sem que haja mudança na atividade larvicida. 
Os resultados obtidos demonstram que é possível desenvolver formulações contendo B. 
thuringiensis sorovar israelensis (IPS-82) eliminando-se esporos viáveis sem alteração da 
atividade larvicida. As formulações irradiadas seriam mais seguras para o meio-ambiente 
e para seres humanos uma vez que a eliminação dos esporos viáveis neutraliza o poten-
cial patogênico de cepas de B. thuringiensis. 
Palavras-chave: biopesticidas, radiação gama, inseticidas larvicidas.
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Introduction
The use of chemical pesticides to 
control insects has revealed several 
different risks for man and the envi-
ronment. The occurrence of chemical 
pesticides resistance in target insects 
and human health problems related to 
their use have been reported (Aranda 
et al., 2000; van Rie and Ferrè, 2000; 
Cadavid-Restrepo et al., 2012). These 
facts prompted the emergence of in-
dustrialized biopesticides based on 
strains of Bacillus thuringiensis, a 
member of Bacillus cereus senso lato 
group, that are capable of producing 
different crystal δ-endotoxins encod-
ed by cry genes. These toxins are the 
active ingredients of a large number 
of preparations used against larvae of 
many insect orders, especially species 
of Coleoptera, Diptera and Lepidop-
tera (Aranda et al., 2000; Libman and 
MacIntosh, 2000; Hansen and Salami-
tou, 2000).
In 1978, a previously described B. 
thuringiensis strain (Goldberg and 
Maragalit, 1977) was designated as the 
14th B. thuringiensis serovar (Bacillus 
thuringiensis var israelensis, H-14) 
(de Barjac, 1978). This bacterium is 
highly toxic for mosquitos and black-
flies (LC50 ranging from 10-13mg/ml 
against fourth instar larvae of many 
species) and presents three inclusions 
containing four main proteins, Cyt1A, 
Cry4A, Cry4B and Cry11A. These 
proteins have different molecular 
weights and act in synergy with other 
Cyt toxins (Federici et al. 2000; Crick-
more et al. 2006; Cadavid-Restrepo et 
al., 2012). This serovar became the 
active compound of industrialized bi-
opesticides used all over the world in 
polycentric programs to control Aedes 
spp. larvae, especially those of Aedes 
aegypti, the yellow fever and dengue 
vector (Mittal, 2003). It is noteworthy 
that in Germany, B. thuringiensis se-
rovar israelensis has been used since 
1981 in a program that is conducted 
by the German Association for Mos-
quito Control (Kommunale Aktion-
sgemeinschaft zur Bekämpfung der 
Stechmückenplage - KABS) (Becker, 
2002).
Despite the advantages of using bi-
opesticides instead of chemical pes-
ticides, there are some considerations 
to be made: B. thuringiensis shares a 
high degree of genetic similarity with 
B. cereus, and it can be distinguished 
from the last mainly by the produc-
tion of parasporal bodies containing 
δ-endotoxins (Yuan et al., 2002). It 
has been described that B. thuringien-
sis strains can carry the same entero-
toxins as B. cereus, suggesting that 
this species may also pose potential 
risk of food poisoning (McIntyre et 
al., 2008; Bartoszewicz et al., 2008).
The aim of the present work was to 
evaluate the application of gamma 
radiation to reduce the presence of vi-
able spores in biopesticides based on 
B. thuringiensis serovar israelensis, in 
order to decrease or prevent the release 
of these spores in the environments 
where the breeding sites of mosquito 
larvae and black flies are located. This 
inactivation methodology can be used 
as an alternative to create an effective, 
safer and more environment-friendly 
biopesticide.
Material and methods
Bacterial strains
The toxigeni c strain B. thuringien-
sis serovar israelensis (H-14) IPS-82 
(LFB-FIOCRUZ 584, deposited in the 
Coleção de Culturas do Gênero Ba-
cillus e Gêneros Correlatos – CCGB 
since 1983) was used. This strain 
was preserved as lyophilized spores 
produced in AES medium according 
to Rabinovitch et al. (Rabinovitch 
et al., 1975) and kept in refrigerator. 
Cytomorphological, biochemical and 
physiological characteristics were 
confirmed as previously described 
(Gordon et al., 1973; Claus and 
Berkeley, 1986). The spores obtained 
from AES medium were conserved in 
distillated water under refrigeration as 
suspensions containing 8x106 colony 
forming unit (CFU)/mL-1.
Production of B. thuringiensis 
IPS-82 formulation
In order to prepare the primary inocu-
lum, the spores contained into two 
tubes with AES medium (at least 90% 
of viable spores) were harvested and 
transferred to 2.0 mL of sterile distil-
lated water and homogenized. One 
milliliter of this suspension (109-1010 
CFU) was transferred to 100 mL of 
liquid medium and incubated at 35oC 
under 120 rpm for 4h. After that, 30 
mL of this growth were inoculated 
in 6L of fermentation medium (Soy 
meal 60-70% of protein 20 g/L; glu-
cose 3.0 g/L; Yeast extract - 1.0 g/L; 
NaCl - 2.0 g/L; MgSO4.7 H2O - 0.3 
g/L; MnSO4.H2O - 0.02 g/L; ZnSO4.7 
H2O - 0.02 g/L; FeSO4.7H2O - 0.02 
g/L; CaCl2 - 0.1 g/L; pH 7.0). Fermen-
tation was carried out in a fermenta-
tor New Brunswick FS-314 (14L to-
tal capacity) under 500rpm promoted 
by two sets of submerged turbin-like 
blades (11cm apart from each other), 
with aeration of 3L of air/min-1 (0.5 
vvm), temperature of 33oC and 20mL 
of antifoam SAG 471 (1:1 in water). 
Total fermentation time was 22h-24h. 
The end-point of the process was 
determined by observation under an 
optical microscope as the point when 
the sporogenesis reached at least 90% 
of free of spores and, in addition, 
by the pH measure (values between 
8.5 and 9.0). After the fermentation, 
the pH of the fermented medium 
was adjusted to 4.5 with laboratory 
grade propionic acid. This medium 
was centrifuged in a continuous flow 
Alfa-Laval Gyro Tester centrifuge at 
3450 rpm. The final formulation was 
obtained by the addition of thickener, 
preservatives, emulsifying, disinte-
grants and water to the centrifuged, 
not exceeding 2% (w/w). These ad-
ditives were mechanically mixed at 
room temperature (25oC to 30oC) un-
til reaching a uniform creamy texture. 
The biomass was kept in the refrig-
erator. The fermentation process gen-
erated around 170g of biomass with 
70% water content.
122
Leon Rabinovitch, Nélida del Mastro, Cláudia Silva, Bernadete Santos, Marcelo Resende, Adriana Vivoni, Regina Alves
Volume 9 number 3  september - december 2014
Irradiation
Aliquots of formulated biomass were 
placed in neutral glass tubes with 
screw caps (75mm x 15mm) until fill-
ing them, and sent to IPEN-CNEN/SP, 
São Paulo to be exposed to an ionizing 
radiation source of Co-60 (Gammacell 
220 Atomic Energy of Canada Ltd.) at 
an average dose of 4.86 h -1 kGy and 
dose uniformity factor of 1.13. Doses 
ranged from 0 to 20 kGy.
Quantification of spores in the 
irradiated biomass
In order to evaluate the effects of dif-
ferent doses of irradiation on the vi-
ability of B. thuringiensis serovar is-
raelensis IPS-82 spores, suspensions 
containing 25 mg or 50 mg of each 
irradiated and non-irradiated samples 
in 25 mL or 50 mL of sterile distil-
lated water were prepared. Two milli-
liters of each suspension were heated 
in 100°C water bath for 15 min. After 
that, heat-treated suspensions were 
diluted in sterile distilled water at 
a ratio of 1:10 and 3 aliquots of 0.1 
mL of the most diluted suspensions 
were spread in three Petri dishes con-
taining nutrient agar culture medium 
(meat peptone 10 g/L; meat extract 3 
g/L; NaCl 5g/L; agar-agar 20 g/L; pH 
7.5). Colony counting was performed 
after incubation at 30°C for 24h-30h 
in order to determine the average 
number of colony forming units per 
mg (CFU mg-1).
Biological assays and 
potency determination
The effect of the irradiation on the 
insecticidal activity was evaluated by 
assays with sensitive Aedes aegypti 
larvae. These assays were conducted 
according to the methodology rec-
ommended by the World Health Or-
ganization (WHO, 1981), with minor 
modifications, in order to determine 
the potency of the material expressed 
by International Toxic Units per mg 
(ITU mg-1). For this purpose, 25 mg 
of each of the irradiated and non-irra-
diated samples were diluted in 50ml 
of sterile distilled water and, after 
homogenization, different aliquots 
were transferred into plastic cups 
containing 25 young L4 larvae of A. 
aegypti (Rockefeller strain) in 150 ml 
of dechlorinated water, comprising 
different concentrations, at least six. 
Four cups for each concentration and 
four cups for control samples, where 
no insecticide was added, were used. 
Mortality of the larvae was evalu-
ated 24 hours after incubation at 27oC 
-28oC, and the lethal concentration 
to 50% of the larvae (LC50) was de-
termined by the analysis of the pro-
bits. The tests were repeated for each 
sample at least three times on differ-
ent days and the mean value and the 
standard deviation were calculated. In 
addition to each test sample, the LC50 
of the standard powder IPS-82 (batch 
#91519) was determined. This pow-
der was provided by the Institut Pas-
teur (Paris, France) and preserved in 
refrigerator under vacuum. Its potency 
was arbitrated at 15,000 ITU per mg, 
and it allowed determining the average 
potency of the bioinsecticide samples 
exposed to different doses of radiation 
and also of those not irradiated.
Data analysis
The analysis was performed to evalu-
ate the effect of irradiation on the lar-
vicidal activity of formulations based 
on B. thuringiensis serovar israelensis 
IPS-82. The value of decimal reduc-
tion (D10) for B. thuringiensis spores, 
representing the radioresistance of the 
spores, was calculated through lin-
ear regression. Larvicidal activity (ex-
pressed as potency) of samples of the 
insecticide that were exposed to dif-
ferent doses of gamma radiation was 
determined in A. aegypti and compared 
with that of the non-irradiated samples. 
The ANOVA test was applied in order 
to compare the potency of irradiated 
and non-irradiated samples.
Results
Effect of irradiation on the via-
bility of B. thuringiensis serovar 
israelensis IPS-82 spores
Samples of formulated insecticides 
biomass containing an average of 3.5 
x 106 viable spores per mg were sub-
jected to different doses of irradiation. 
Table 1 shows the average number of 
viable spores (N) per mg for each dose 
of radiation (D) used for inactivation. 
A linear response between N and D 
logarithms was obtained (Figure 1).
The value of decimal reduction (D10) 
for B. thuringiensis spores was 2.89. 
According to the equation of the curve 
obtained by the correlation of the data 
showed in Table 1, only one spore, 
from 3.5x106 that were irradiated, sur-
vive after a dose of 19.83 kGy. The 
application of a dose of 20 kGy en-
sured total inactivation of the spores 
in the insecticide.
Table 1. Correlations among irradiation dose with Co-60, average potency and Bacillus 
thuringiensis sorovar israelensis IPS-82 residual viable spores (N) in formulated biomass. 
Dose (kGy)
Average potency 
(ITU/mg) ±SD1,2
Average of viable spores 
(N) (CFU/mg)
Log N
0 833 142 3.50 x 106 6.54
5 920  27 4.10 x 105 5.61
7.5 838  43 4.60 x 104 4.66
10 876  218 2.25 x 103 3.35
12.5 1060  277 6.00 x 101 1.78
15 1019±10 4.30x101 1.64
17.5 1033  95 1.25 x 101 1.10
20 1146  89 0 0
Notes: (1) Effect on Aedes aegypti young L4 larvae. (2) Average values for triplicate experiments.
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Effect of irradiation on 
the larvicidal activity of 
emulsifiable concentrate 
based on B. thuringiensis 
serovar israelensis IPS-82
The variance analysis of the larvicidal 
activity of samples of the insecticide 
(expressed as potency) revealed that 
there is no statistical significance be-
tween the mean values  of different 
treatments (Table 1). These results in-
dicate that there was no change in the 
effectiveness of insecticide after irra-
diation with Co-60 up to a maximum 
dose of 20 kGy (p=0.05, confidence 
interval 95%).
Discussion
This study showed that it is possible 
to develop formulations containing 
B. thuringiensis serovar israelensis 
(IPS-82) eliminating viable spores 
with gamma radiation without affect-
ing the larvicidal activity. There are a 
few works in the literature reporting 
irradiation of B. thuringiensis serovar 
israelensis with Co-60. One of these 
works reported that gamma radiation 
doses of 20-25kGy produced a 20-
30% reduction in the effectiveness of 
B. thuringiensis serovar israelensis 
powder against L4 Culicidae larvae 
(Becker, 2002). Melo-Santos et al. 
(2009) reported that two Bti IPS-82 
preparations (tablet and technical 
powder) lost up to 83% of potency 
after irradiation. Asano et al. (2000) 
found that gamma irradiation of B. 
thuringiensis serovar kurstaki spores 
results in a dramatic reduction of 
their effect against the diamondback 
moth larvae, Plutella xylostella, indi-
cating that live spores are necessary 
to achieve full insecticidal activity 
against these Lepidoptera larvae. 
Our results showed that irradiation 
with Co-60 (ranging from 5 to 20 
kGy) gradually decreases the amount 
of viable spores of B. thuringiensis 
serovar israelensis in the formulated 
biomass. Moreover, it was shown that 
the larvicidal activity of the prepara-
tion remains unchanged. Thus, the 
results suggest that the mosquitocidal 
activity of the B. thuringiensis serovar 
israelensis strain IPS-82 (LFB-FI-
OCRUZ 584) used in the formulation 
tested does not depend on the germi-
nation of the spore inside the A. ae-
gypti larvae and thus it is not affected 
by radiation. Our results showed that 
irradiation with Co-60 (ranging from 
5 to 20 kGy) gradually decreases the 
amount of viable spores of B. thur-
ingiensis serovar israelensis in the 
formulated biomass, but the larvicidal 
activity of the preparation remains 
unchanged. The discrepancy between 
the results presented in this work 
and those described by Asano et al.
(2000) and Becker (2002) regarding 
the insecticidal efficiency of irradi-
ated spores may be, in part, due to 
the different B. thuringiensis strains 
and serovars that were used in each 
study. This is particularly more rele-
vant when comparing our results with 
those of Asano et al. (2000) where the 
germination of the spores seems to 
play an important role on the patho-
genicity of B. thuringiensis serovar 
kurstaki on P. xylostella. 
In this work, an “in house” emulsifi-
able formulation was used instead of 
the commercial wettable powder used 
by Becker (2002) or the table and the 
technical powder used by Melo-San-
tos et al. (2009). In contrast with re-
sults reported in both studies, we did 
not observe any significant loss of po-
tency after the irradiation. Moreover, 
it seems that the addition of proprionic 
acid to the fermentation product, cre-
ating an acidic environment, protects 
the crystalline structure of the pro-
toxin. Our results suggest that the type 
of formulation may influence the con-
servation of the potency in irradiated 
products and this should be consid-
ered when developing these products.
The original, non-irradiated formu-
lation described in the present study 
was once tested in the field in three 
streams with different flows located 
in Rio Grande do Sul, Brazil (Mardini 
et al., 1999). The formulation tested 
against larvae of Simulium spp., in 
doses ranging from 20 to 40 ppm per 
point of application, was able to to-
tally eliminate the larvae of this insect 
in a distance of 380m from the point 
of application (Mardini et al., 1999). 
Nevertheless, further studies are nec-
essary to evaluate the efficacy of the 
irradiated formulation in the field. 
The present work demonstrates that it 
is possible to develop industrially for-
mulated products containing B. thur-
ingiensis serovar israelensis (IPS-82) 
eliminating viable spores with gamma 
radiation without affecting the larvi-
cidal activity. Irradiated formulations 
would be safer for the environment 
and humans since the elimination of 
Figure 1. Radio-susceptibility of Bacillus thuringiensis serovar israelensis IPS-82 spores 
and decimal reduction value (D10). D – radiation dose; N - residual viable spores in formu-
lated biomass.
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viable spores abolishes the pathogenic 
potential of insecticidal B. thuring-
iensis strains. Further studies should 
evaluate the application of the meth-
odology described here on different 
formulations using other B. thuring-
iensis serovars active against agricul-
tural pests, in order to assess how the 
insecticidal activity of these strains is 
affected by radiation.
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